Company / Operating Cash Flow
BioLife Solutions, Inc. Operating Cash Flow History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
$20.1M
FY2025
5-year range
-$12.5M / $20.1M
FY2021-FY2025
Trend
+138.6%
vs FY2024
Sector context
#128 of 158
Health Care
What the data says
BioLife Solutions, Inc.'s operating cash flow of $20M is lower than 81% of companies in the Health Care sector (FY2025). Operating Cash Flow has fluctuated over the past 10 years, ranging from -$12M in FY2023 to $20M in FY2025.
Based on SEC 10-K filings.
$20M in FY2025 with a 5-year CAGR of +24.8%.
Improved from -$12M to $20M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +24.8%
- 10-Year CAGR
- -
Sector benchmark
Bottom 19% in Health CareTop 81% of 158This company $20.1M Sector average $1.0B
▼
-98.1% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.8%, indicating consistent growth.
- In FY2025, operating cash flow increased 138.6% year-over-year.
- Ranks #128 out of 158 companies in the Health Care sector.
- Lowest operating cash flow in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 4.67 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $20.1M | +138.6% |
| FY2024 | $8.4M | +167.5% |
| FY2023 | -$12.5M | -47.2% |
| FY2022 | -$8.5M | -84.8% |
| FY2021 | -$4.6M | -169.1% |
| FY2020 | $6.6M | +447.8% |
| FY2019 | $1.2M | +209.4% |
| FY2018 | $392.0K | -35.2% |
| FY2017 | $605.0K | +114.0% |
| FY2016 | -$4.3M | +13.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026